| Authors: |
Chan-Penebre E; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Kuplast KG; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Majer CR; Warp Drive Bio, Cambridge, Massachusetts, USA., Boriack-Sjodin PA; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Wigle TJ; Warp Drive Bio, Cambridge, Massachusetts, USA., Johnston LD; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Rioux N; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Munchhof MJ; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Jin L; Agile Biostructure Solutions, Cambridge, Massachusetts, USA., Jacques SL; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., West KA; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Lingaraj T; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Stickland K; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Ribich SA; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Raimondi A; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Scott MP; Genentech, San Francisco, California, USA., Waters NJ; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Pollock RM; Warp Drive Bio, Cambridge, Massachusetts, USA., Smith JJ; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Barbash O; Cancer Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Pappalardi M; Cancer Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Ho TF; Department of Biological Reagents and Assay Development, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Nurse K; Department of Biological Reagents and Assay Development, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Oza KP; Department of Biological Reagents and Assay Development, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Gallagher KT; Discovery Core Technologies and Capabilities, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Kruger R; Cancer Epigenetics DPU, GlaxoSmithKline, Collegeville, Pennsylvania, USA., Moyer MP; Raze Therapeutics, Cambridge, Massachusetts, USA., Copeland RA; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Chesworth R; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA., Duncan KW; Departments of Biology and Molecular Discovery, Epizyme, Inc., Cambridge, Massachusetts, USA. |
